Prenetics Global Limited (PRE)
4.09
0.03 (0.74%)
At close: Mar 24, 2025, 3:58 PM
4.15
1.47%
After-hours: Mar 24, 2025, 06:53 PM EDT
0.74% (1D)
Bid | 2.78 |
Market Cap | 49.97M |
Revenue (ttm) | 24.58M |
Net Income (ttm) | -47.13M |
EPS (ttm) | -3.73 |
PE Ratio (ttm) | -1.1 |
Forward PE | -9.46 |
Analyst | Buy |
Ask | 4.31 |
Volume | 852 |
Avg. Volume (20D) | 12,024 |
Open | 4.06 |
Previous Close | 4.06 |
Day's Range | 4.06 - 4.20 |
52-Week Range | 2.85 - 7.84 |
Beta | -0.31 |
About PRE
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Website https://www.prenetics.com
Analyst Forecast
According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 120.05% from the latest price.
Stock Forecasts5 months ago
+19.13%
Prenetics Global shares are trading higher followi...
Unlock content with
Pro Subscription
7 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.

2 years ago · fool.com
Why Prenetics Global Stock Is Skyrocketing TodayThe company announced a key FDA clearance.